Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 39 min 49 sec ago

Flamel Technologies Announces FDA Approval of VAZCULEP

Mon, 06/30/2014 - 13:10
LYON, FRANCE--(Healthcare Sales & Marketing Network) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for VAZCULEP™ (phenylephrine hydrochloride). VA...
Biopharmaceuticals, FDA
Flamel Technologies, VAZCULEP, phenylephrine hydrochloride

Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer

Mon, 06/30/2014 - 13:06
CAMBRIDGE, MA--(Healthcare Sales & Marketing Network) - Proteostasis Therapeutics, Inc., a developer of novel therapeutics regulating protein homeostasis to improve outcomes for patients with orphan and neurodegenerative diseases, today announced the appoi...
Biopharmaceuticals, Personnel
Proteostasis Therapeutics

CHMP Recommends EU Approval of VIZAMYL(TM) (Flutemetamol F18 Injection) for PET Imaging of Beta Amyloid Plaque

Mon, 06/30/2014 - 12:59
PET Imaging Agent Receives Positive Opinion CHALFONT ST. GILES, England--(Healthcare Sales & Marketing Network)--GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Hu...
Biopharmaceuticals, Radiology, Neurology, Regulatory
GE Healthcare, VIZAMYL, Flutemetamol F18, PET , Alzheimer’s disease, imaging

EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union

Fri, 06/27/2014 - 13:48
TARRYTOWN, N.Y., June 27, 2014 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (REGN) today announced that EYLEA® (aflibercept) Injection has been recommended for approval by the European Committee for Medicinal Products f...
Biopharmaceuticals, Ophthalmology, Regulatory
Regeneron Pharmaceuticals, EYLEA, aflibercept, diabetic macular edema

Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor) in Eight Non-G551D Gating Mutations

Fri, 06/27/2014 - 13:42
In Europe, approximately 250 people ages 6 and older have one of 8 additional gating mutations KALYDECO is the first medicine to treat the underlying cause of CF in people with non-G551D gating mutations EYSINS, Switzerland--(Healthcare Sales & Marke...
Biopharmaceuticals, Regulatory
Vertex Pharmaceuticals, KALYDECO, ivacaftor, cystic fibrosis

Bristol-Myers Squibb Receives Positive CHMP Opinion for Daklinza(R) (daclatasvir) for Treatment of Chronic Hepatitis C in the European Union

Fri, 06/27/2014 - 13:36
Daklinza in combination with other agents would offer a potential cure for HCV patients with high unmet needs who urgently require treatment, if approved PRINCETON, N.J.--(Healthcare Sales & Marketing Network)--Bristol-Myers Squibb Company (BMY) today a...
Biopharmaceuticals, Regulatory
Bristol-Myers Squibb, Daklinza, daclatasvir, hepatitis C

Eliquis(R) (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE

Fri, 06/27/2014 - 13:30
PRINCETON, N.J. & NEW YORK--(Healthcare Sales & Marketing Network)--Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...
Biopharmaceuticals, Regulatory
Bristol-Myers Squibb, Pfizer, Eliquis, apixaban, DVT , pulmonary embolism

Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa) Presented at the European Working Group on Gaucher Disease 2014 11th Meeting

Fri, 06/27/2014 - 13:22
CARMIEL, Israel, June 27, 2014 -- (Healthcare Sales & Marketing Network) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (PLX.TA), announced today that new clinical data on ELELYSOTM (taliglucerase alfa) will be presented at the European Working Group on ...
Biopharmaceuticals
Protalix BioTherapeutics, ELELYSO, taliglucerase alfa, Gaucher Disease

Dune Medical Devices Raises $21 Million in Funding

Thu, 06/26/2014 - 16:26
Two-stage Financing will Support Expansion of Commercial Rollout of MarginProbe CAESAREA, Israel, June 26, 2014 -- (Healthcare Sales & Marketing Network) -- Dune Medical Devices, announced today that it has successfully completed the first of a two sta...
Devices, Diagnostics, Oncology, Venture Capital
Dune Medical Devices, MarginProbe

Esperion Therapeutics Announces the Appointment of Gilbert S. Omenn, M.D., Ph.D. to Board of Directors

Thu, 06/26/2014 - 16:22
ANN ARBOR, Mich.--(Healthcare Sales & Marketing Network)--Esperion Therapeutics, Inc. (ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering th...
Biopharmaceuticals, Cardiology, Personnel
Esperion Therapeutics, hypercholesterolemia

Ivenix Designs Next-Generation Infusion Management System to Transform Infusion Pump Market

Thu, 06/26/2014 - 16:18
New Infusion Platform Combines Simple and Intuitive User Interface with State-of-the Art Information Technology and Adaptive Pumping System that Measures Flow to Improve Patient Safety and Workflow Efficiency AMESBURY, Mass., June 26, 2014 -- (Healthcar...
Devices, Drug Delivery
Ivenix, infusion pump

Tris Pharma Expands RandD Team with addition of Chief Medical Officer and Vice President of Regulatory Affairs

Thu, 06/26/2014 - 16:13
MONMOUTH JUNCTION, N.J., June 26, 2014 -- (Healthcare Sales & Marketing Network) -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced two key additions to its' executive team: Sally A. Be...
Biopharmaceuticals, Personnel
Tris Pharma

Deal Labs Closes Oversubscribed Series A for Consano Medical; Raising Capital for Nueon Inc.

Thu, 06/26/2014 - 13:12
New financing platform raises capital for medical device companies and partnerships SAN FRANCISCO--(Healthcare Sales & Marketing Network)--Deal Labs, Inc., an online financing platform with targeted capital-raising solicitation technology, announced the...
Devices, Venture Capital
Deal Labs, Consano Medical, Nueon Inc

Sham Controlled Pilot Study Shows electroCore’s Non Invasive Vagus Nerve Stimulation Therapy for the Prevention of Migraine is Safe and Reduces the Number of Headache Days

Thu, 06/26/2014 - 13:07
BASKING RIDGE, N.J.--(Healthcare Sales & Marketing Network)--Today, June 26, at the American Headache Society (AHS) meeting in California two poster presentations reported the results of the sham controlled pilot study that examined the use of electroCore’...
Devices, Neurology
ElectroCore, vagus nerve stimulation, migraine

Boston Scientific Welcomes New Guidance on the use of Cardiac Technologies for Patients With Arrhythmia or Heart Failure

Thu, 06/26/2014 - 13:01
HEMEL HEMPSTEAD, England, June 26, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific welcomes the National Institute for Health and Care Excellence (NICE) guidance on the use of implantable cardioverter defibrillators (ICDs) and cardiac ...
Devices, Cardiology
Boston Scientific, ICD , CRT , CRT-D, implantable cardioverter defibrillator

Titan Spine Receives Market Registration Approval in Australia and New Zealand for its Endoskeleton(R) Interbody Fusion Devices

Wed, 06/25/2014 - 15:26
Expands registration to Four Broad Global Markets: US, EU, Australia and New Zealand Underscores growing adoption of titanium devices that participate in the fusion process MEQUON, Wis.--(Healthcare Sales & Marketing Network)--Titan Spine, a medica...
Devices, Orthopaedic, Neurosurgery, Regulatory
Titan Spine, Endoskeleton, Interbody Fusion

Zynex Appoints Director of Business Development

Wed, 06/25/2014 - 15:23
LONE TREE, CO--(Healthcare Sales & Marketing Network) - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological di...
Devices, Personnel
Zynex, NeuroDiagnostics

Owens and Minor to Acquire Medical Action Industries, a Leading Provider of Procedure-Based Kits and Trays

Wed, 06/25/2014 - 15:15
Acquisition of Medical Action aligns with Owens & Minor's strategy of Connecting the World of Medical Products to the Point of CareTM by expanding reach to the patient Medical Action's kitting capabilities complement Owens & Minor's existing procedure-b...
Devices, Mergers & Acquisitions
Medical Action Industries, Owens & Minor, procedure tray

Akers Biosciences Signs Agreement With Medline -- a Major US Distributor

Wed, 06/25/2014 - 15:10
THOROFARE, N.J., June 25, 2014 -- (Healthcare Sales & Marketing Network) -- Akers Biosciences, Inc. (AKER) (AKR.L) (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and testing products, announc...
Diagnostics, Distribution
Akers Biosciences, Medline, Heparin, Heparin-Induced Thrombocytopenia

Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer

Tue, 06/24/2014 - 19:07
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Editas Medicine, a transformative genome editing company, today announced the appointment of Katrine S. Bosley as chief executive officer. Ms. Bosley brings to Editas more than 20 years of experienc...
Biopharmaceuticals, Personnel
Editas Medicine, genome editing

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong